Results 251 to 260 of about 148,802 (383)

Individualizing the choice of surgical therapy for gastroesophageal reflux disease. [PDF]

Curr Opin Gastroenterol
Bonavina L.
europepmc   +1 more source

The inter-relationship between gastroesophageal reflux disease (GERD) & H. pylori: Chicken or egg?

, 2000
D. Morton, Kama D. Bardhan
openalex   +1 more source

The Association of Avoidant/Restrictive Food Intake Disorder (ARFID) and Neurogastroenterology Disorders (Including Disorders of Gut–Brain Interaction [DGBI]): A Scoping Review

Neurogastroenterology &Motility, EarlyView.
This scoping review found that avoidant/restrictive food intake disorder (ARFID) symptoms are highly prevalent in neurogastroenterology disorders such as disorders of gut–brain interaction (DGBI), and vice versa. Patients with an ARFID‐neurogastroenterology disorder overlap were found to have higher anxiety and depression levels, and a lower quality of
Hiba Mikhael‐Moussa, Valérie Bertrand, Emeline Lejeune, Claire Dupont, Alexandra Aupetit, Najate Achamrah, Chloé Melchior   +6 more
wiley   +1 more source

Antireflux mucoplasty with the reopenable clip-over-the-line method for refractory gastroesophageal reflux disease. [PDF]

Endoscopy
Lin J, Fan L, Lu S, Lin M.
europepmc   +1 more source

H. pylori cagA, vacA and iceA genotype associations with gastroesophageal reflux disease (GERD) compared to other upper gastrointestinal diseases

, 2000
Andreas Leodolter, K. Wolle, Matthias Ebert, Wolfgang Köenig, Peter Malfertheiner   +4 more
openalex   +1 more source

A Review of the Mechanisms of Action of the Herbal Medicine, STW 5‐II, Underlying Its Efficacy in Disorders of Gut–Brain Interaction

Neurogastroenterology &Motility, EarlyView.
The pathophysiology of functional dyspepsia and irritable bowel syndrome includes altered motility, secretion, sensitivity to sensory signals, impaired epithelial barrier function, inflammation, and gut dysbiosis. The phytomedicine, STW 5‐II, represents a multi‐targeted approach, addressing these pathophysiologies.
Anita Annaházi, Rudolf Bauer, Thomas Efferth, Mohamed T. Khayyal, Michael Schemann, Gudrun Ulrich‐Merzenich, Christine Feinle‐Bisset   +6 more
wiley   +1 more source

Unveiling the intricacies: Insight into gastroesophageal reflux disease. [PDF]

World J Gastroenterol
Wickramasinghe N, Devanarayana NM.
europepmc   +1 more source

24-Hour monitoring of acid clearance in patients with gastroesophageal reflux disease: Assessed by ambulatory esophageal manometry and pH-metry

, 2000
Junichi Akiyama, Kei Matsueda, Shoda Ryosuke, Shigeru Yamato, Akira Muraoka, Masako Asayama, Hideya Yoshinaga, Hiroyuki Oka, Hitoshi Baba, Hiroko Yamashita, Naohiko Masaki, Shigeki Hayashi   +11 more
openalex   +1 more source

Validation of the PROMIS Global Physical and Mental Health Scale for Gastrointestinal Disorders: A Large‐Scale Cross‐Sectional Survey

Neurogastroenterology &Motility, EarlyView.
The 4‐item revised version of the Hays model from the PROMIS Global Health Scale exhibits stronger psychometric properties than the original model. This ultra‐brief assessment tool is a reliable measure for evaluating quality of life in both gastrointestinal and non‐gastrointestinal cohorts.
Pragalathan Apputhurai, Olafur S. Palsson, Shrikant I. Bangdiwala, Ami D. Sperber, Antonina Mikocka‐Walus, Simon R. Knowles   +5 more
wiley   +1 more source

PGU3: DECISION ANALYSIS OF OMEPRAZOLE VERSUS LAPAROSCOPIC NISSEN FUNDOPLICATION FOR TREATING PATIENTS WITH SEVERE GASTROESOPHAGEAL REFLUX DISEASE

, 2000
CR Cantrell, SW Wilde, BC Martin
openalex   +1 more source